📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Theraclion

1.1 - Company Overview

Theraclion Logo

Theraclion

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of high-intensity focused ultrasound (HIFU) echotherapy medical equipment, combining HIFU with standard ultrasound for non-invasive treatment and target localization. Solutions include SONOVEIN for varicose veins; ECHOPULSE for thyroid nodules and breast fibroadenoma; CURE-OP for combinational cancer therapy integrating ultrasound with radiotherapy; and EPack single-use disposables for cooling and coupling.

Products and services

  • CURE-OP: Modular HIFU platform for combinational cancer therapy, integrating ultrasound with radiotherapy to enhance treatment efficacy and safety
  • ECHOPULSE: Clinical-grade non-invasive echotherapy system treating thyroid nodules and breast fibroadenoma using high-intensity focused ultrasound combined with standard ultrasound for precise targeting
  • Employs EPack for cooling and coupling
  • SONOVEIN: Industrial-grade non-invasive echotherapy system for varicose veins, using high-intensity focused ultrasound combined with standard ultrasound for accurate target localization
  • Utilizes EPack to maintain cooling and coupling during treatments

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Theraclion

Molecular Templates Logo

Molecular Templates

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical therapies for cancer and other serious diseases, leveraging a proprietary engineered toxin body (ETB) platform with unique mechanisms of action. Pipeline includes MT-6402 (PD-L1), MT-8421 (CTLA-4), and MT-0169 (CD38). Operates a multi-product cGMP manufacturing facility in Austin, TX to supply clinical trial materials for internal and partnered ETB programs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Molecular Templates company profile →
Koya Medical Logo

Koya Medical

HQ: United States Website
  • Description: Provider of breakthrough treatments for lymphedema and venous diseases, as a transformative healthcare company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Koya Medical company profile →
MirImmune Bio Logo

MirImmune Bio

HQ: United States Website
  • Description: Provider of biopharmaceutical R&D focused on new and improved cancer immunotherapies, combining immune checkpoint inhibition and cell-based immunotherapies, aiming to achieve long-term survival of cancer patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MirImmune Bio company profile →
WntResearch Logo

WntResearch

HQ: Sweden Website
  • Description: Provider of anti-metastatic cancer therapies targeting WNT5A signaling. Pipeline includes Foxy-5, a peptide drug candidate that mimics WNT5A to reduce cancer cell mobility and spread (Phase I; reconstitutes Wnt-5a effects in breast cancer cells), and Box-5, a peptide in preclinical development that antagonizes Wnt-5a.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full WntResearch company profile →
Favrille Logo

Favrille

HQ: United States Website
  • Description: Provider of targeted immunotherapies, focused on research, development and commercialization for the treatment of cancer and other diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Favrille company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Theraclion

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Theraclion

2.2 - Growth funds investing in similar companies to Theraclion

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Theraclion

4.2 - Public trading comparable groups for Theraclion

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Theraclion

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Theraclion

What does Theraclion do?

Theraclion is a provider of high-intensity focused ultrasound (HIFU) echotherapy medical equipment, combining HIFU with standard ultrasound for non-invasive treatment and target localization. Solutions include SONOVEIN for varicose veins; ECHOPULSE for thyroid nodules and breast fibroadenoma; CURE-OP for combinational cancer therapy integrating ultrasound with radiotherapy; and EPack single-use disposables for cooling and coupling.

Who are Theraclion's competitors?

Theraclion's competitors and similar companies include Molecular Templates, Koya Medical, MirImmune Bio, WntResearch, and Favrille.

Where is Theraclion headquartered?

Theraclion is headquartered in France.

How many employees does Theraclion have?

Theraclion has 1,000 employees 🔒.

When was Theraclion founded?

Theraclion was founded in 2010 🔒.

What sector and industry vertical is Theraclion in?

Theraclion is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Theraclion

Who are the top strategic acquirers in Theraclion's sector and industry

Top strategic M&A buyers and acquirers in Theraclion's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Theraclion?

Top strategic M&A buyers groups and sectors for Theraclion include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Theraclion's sector and industry vertical

Which are the top PE firms investing in Theraclion's sector and industry vertical?

Top PE firms investing in Theraclion's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Theraclion's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Theraclion's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Theraclion's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Theraclion include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Theraclion's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Theraclion?

The key public trading comparables and valuation benchmarks for Theraclion include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Theraclion for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Theraclion with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Theraclion's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Theraclion with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Theraclion's' sector and industry vertical?

Access recent funding rounds and capital raises in Theraclion's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Theraclion

Launch login modal Launch register modal